Document is current
Any future updates will be listed below
-
Authors
Khani, Mohammadreza
Sass, Lucas R.
Arters, Ostin
Meyer, Kathrin
Martin, Bryn A.
- License Information
-
More Information
Article History
Received: 15 April 2025
Accepted: 7 October 2025
First Online: 4 November 2025
Declarations
:
: All authors have approved the manuscript submission. The content of this manuscript has not been published or submitted for publication elsewhere.
: MK, LS, KM, BAM are employees at Neela Therapeutics. BAM has been a scientific advisory board member for Novoron Biosciences, Alcyone Lifesciences, Anuncia Medical, Chiari and Syringomyelia Foundation, The International Society for Hydrocephalus and CSF Disorders, and The International CSF Dynamics Society. BAM has received research funding from Biogen Inc., Genentech Inc., KBR Wyle, Alcyone Lifesciences Inc., Minnetronix Inc. and Voyager Therapeutics. BAM has served as a consultant to Flux Neuroscience, Genentech, Roche, Minnetronix, SwanBio Therapeutics, Praxis Medicines, Cerebral Therapeutics, CereVasc, InviCRO, Neurosyntec, Behavior Imaging, Anuncia Medical, and Voyager Therapeutics.
